
iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes
VJHemOnc Podcast
Patient Eligibility and Challenges in Transplantation and Immunotherapies for AML
This chapter explores the patient population most suitable for transplantation and immunotherapies in AML, highlighting the exclusion of TP53 complex curio types and the challenges posed by the immunosuppressive microenvironment for CAR-T therapy. It proposes an innovative allergen egg type product and the importance of a tailored approach for this specific group.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.